Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell entities : Morphosys ag save search
Incyte and MorphoSys Announce the European Commission Approval of Minjuvi® (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-08-26 (Crawled : 21:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.28%
H: 0.89%
C: -2.02%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.49%
H: 1.34%
C: -0.42%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.25%
H: 0.33%
C: -1.05%
treatment europe approval t-cell
Incyte Announces Health Canada Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-08-24 (Crawled : 13:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -2.7%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 4.43%
H: 0.21%
C: -0.55%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.3%
H: 0.03%
C: -0.29%
canada approval treatment approval t-cell
MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 13:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 12:15) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.